Navigation Links
Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary

New Jersey The nations publicized gay governor, James E. McGreevy appears to be knocking on a different door. This time he has managed to be in the news for the right reasons. He has been welcomed into the seminary and has become an Episcopalian.

Former Gov. James E. McGreevy, who was brought up as a Roman Catholic, was officially inducted into the Episcopal religion on Sunday at St. Bartholomew's Church in New York. He is presently undergoing the church's "discernment" phase, which is customary before he takes up full-fledged seminary obligations. People are still speculating if this move is driven by a desire to become a priest.

McGreevy, 49, had created a stir in 2004, when he announced his gay status; at that time he had gone public about his extramarital affair with a male aide. Following this admission, he had also offered to relinquish his post as governor. The aide had gone on to deny the affair, on the contrary had blamed the governor for harassing him.

The Episcopal Church, school spokesman Bruce Parker said, "Mr. McGreevy has been admitted to the master of divinity program and he will be starting in the fall, where Mr. McGreevy goes with this is up to him. We have a lot of people studying here who are not interested in ordination at all."

It is not binding on priests serving at The Episcopal Church to remain celibate.


'"/>




Page: 1

Related medicine news :

1. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
2. An Enzyme That Turns a One –time Experience into a long-time Memor
3. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
4. Allergy Alarm: Sams Choice Milk Chocolate Turns Bitter with Undisclosed Nuts
5. Where Mothers Skin Turns Into Food For Offspring
6. A Worm Turns: Banking on Blood From a Little Lugworm
7. Toy Story Turns Bitter-Christmas Toys, No Music to the Ears!
8. Drug Meant to Heal Turns ‘heel’ and Hars
9. Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down
10. Well-known Kerala Actor, Mohanlal, Turns AIDS Activist
11. Fashion Fraternity Turns Socially Conscious
Post Your Comments:
(Date:7/26/2008)...device giving patients freedom of movement, better...HealthDay News) -- An automated artificial kidney ...alysis patients what the insulin pump is to diabet...al kidney (AWAK) works better than conventional di...of Clinical and Experimental Nephrology . , "W...
(Date:7/25/2008)....Y., July 25 /PRNewswire-USNewswire/ -- Anthony Sh...ty Officer and Vice President,of Strategic Plannin..., a,national foundation committed to improving U.S... foundation,s Program on Health Care Quality,Impro...m.com/cgi-bin/prnh/20080725/DC28791LOGO ), Board...
(Date:7/25/2008)...ponse after antiretroviral therapy may be due to g...thDay News) -- A new study challenges the long-hel...the immune system,s ability to restore itself afte...retroviral therapy (HAART). , From 50 percent t...nfected with HCV. Intravenous drug use is the main...
(Date:7/25/2008)...ffers patients consumers tips and encourages them ...HARRISBURG, Pa., July 25 /PRNewswire-USNewswire/ -...supports "National Patient Safety Day" which,is a ...milies to,participate fully in their healthcare by... about their surgery or illness., "We understand ...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...ith high-risk genes could increase their chances o...David Goldgar // at the International Agency for R...He found that women with BRCA1 and 2 (breast cance...had undergone a chest X-ray were 54 percent more l...
...il (ACC) and UNICEF have renewed their internation... under which they will support// the global campai...AIDS'. The two bodies will also promote the right...eation and promote girls' education in South Asia,...
...?gren’s (SHOW-grins) syndrome was found to be the ...or long periods. Typical signs and symptoms inclu...y vision, a dry mouth that causes difficulty swall...tid glands. The parotids are a pair of salivary gl...
... Clinic Health Center have identified and announce... Dermatitis, an allergic disease with red, sore it...ike chemicals, medications, certain plants, jewell...ls, creams, etc. The July issue of Mayo Clinic He...
Other Medicine News:
(Date:7/23/2008)...Body Have Greater Concentrations of,Stem Cells, A...wire/ -- Fat removed,from the lower abdomen and in...xcellent source of stem cells, with higher stem ce...ports a Brazilian-based study in August,s,Plastic ...l journal of the,American Society of Plastic Surge...
(Date:7/23/2008)...k with Protein Therapeutics that Modulat...IDGE, Mass., July 23 /- Taligen Thera...rporate growth plan with the,appointment of Abbie ...e,establishment of its headquarters in Cambridge, ...a co-founder of the company who remains president....
(Date:7/22/2008)...- Nonin Medical, a leading innovator,of physiologi...as entered,the clinical testing phase with its bre...turation. Today,s most common application for this...gional blood oxygenation,in the brain -- cerebral ...n ongoing clinical study at the,Duke University Me...
(Date:7/22/2008)...fficacy of Treating Patients with ... YONGIN-SI, South Korea, July 22 /-,J...io), and its South,Korean partner Green Cross Corp...e I clinical trial of its first-in-class lead prod...tolerated and resulted in clear,anti-cancer effica...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 1USP Convention and Chinese Pharmacopoeia Commission sign Memorandum of Understanding 2430 2U of I researcher develops power packed soy breakfast cereal 2428 1U of I researcher develops power packed soy breakfast cereal 2428 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 1AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 2AACN Applauds Senator Richard Durbin for Introducing the Troops to Nurse Teachers Act of 2008 13710 3United Mitochondrial Disease Foundation Statement on Vaccines Autism and Mitochondrial Disease 13708 1
...ort Rationale for Targeting Pro-Inflammatory,Prote...e-FirstCall/ --,MedImmune, Inc. today announced th...ing a role for high mobility group box,protein-1 (...ology,of systemic autoimmune diseases such as syst...toid arthritis. Data to be,published in the May 20...
...pril 19, 2007 /PRNewswire-FirstCall/ --,VioQuest P...aceutical company focused on acquiring, developing...nounced data from its,preclinical studies of VQD- ...treatment of solid and hematologic tumors.,Pre-cli...2007,Annual Meeting of the American Association fo...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
...ly adjustable dispensing head, and disposable, pre...aralleled flexibility and cost-efficiency to micro... of its kind to offer fast dispensing of fluids in...lso offers the added benefit of being able to acco...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat
The Labcyte Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nL using a new "touchless" transfer technology based on focused acoustic energy. Mon
Precise, nanoliter-volume liquid handling capability allows you to accurately dispense volumes as small as 5 nanoliters. Precision robotics and flexible software ensure accurate, repeatable X/Y motio
Medicine Products: